· 个股论点

XFAB确认CPO与800V布局,验证投资逻辑,预期2027-2028年估值重估。

涉及标的:

相关概念: CPO 共封装光学光子学 Photonics

中文翻译

关于 $XFAB 投资者关系(ER)电话会议纪要: 简单回顾一下,我对 $XFAB 晶圆代工增长机会的观点源于碳化硅(SiC)在800V架构中的应用,以及光子工厂(MTP)在共封装光学(CPO)领域的适用性。 - $XFAB:“我们在共封装光学方面正在取得进展”。 - “向800V架构的过渡……预计将推动对碳化硅(SiC)和氮化镓(GaN)的需求……对 $XFAB 而言”。 所以,那些自信地唱空 $XFAB、声称其“在800V、光子学、CPO方面零敞口”的分析师/人士,结果被证明完全错了。 在我分享观点时,行业材料显示日月光(ASE)等公司将光子工厂+ $XFAB 列为欧洲即将崛起的CPO玩家。 filings显示他们普遍涉及如 $NVTS / $POWI 等名称。 很高兴 $XFAB 出面明确澄清,表示他们正在开发CPO/800V相关技术。 回到ER纪要: - “我们继续预计光子学量产将于2028年开始”。公司目前有三个硅光子项目正在与关键合作伙伴开发中。 我原本以为会在2027年下半年爬坡,但可能早估了几个月。 - 多个新的数据中心设计订单,例如3个新的碳化硅设计订单(与800V部署启动后2027年普遍爬坡一致)。 因此,一旦这些在2027-2028年爬坡(市场往往会提前定价),我预计 $XFAB 将基于增长机会获得估值重估。 总结: - 当前营收数据并不惊艳。 - $XFAB 确认直接涉足CPO和800V转型(这是投资逻辑的最大胜利) - 800V敞口带来的碳化硅机会(应在2027年) - 光子学量产时间表为2028年 很高兴CPO/800V敞口的投资逻辑在此次ER中得到确认。营收爬坡可能需要一点等待时间。

英文原文

For $XFAB ER transcript: Just to recap, my idea on $XFAB foundry growth opportunities stemmed from SiC for 800v and photonixfab/MTP for CPO applicability. - $XFAB: "We are making progress in co-packaged optics". - "The transition to 800v... is expected to support demand for both SiC and GaN... for XFAB" So those analysts/people that were confidently bearposting about $XFAB that they had "0 exposure to 800V, photonics, CPO" just turned out plainly wrong. At the time I shared my idea, industry materials showed ASE and others cited photonixfab + XFAB as an upcoming CPO player in EU. And filings showed they had exposure names like $NVTS / $POWI in general. So glad $XFAB went out to explicitly clear things up to state they were developing in CPO/800v. Okay back to the ER: - "We continue to expect photonics volume production to start in 2028". Company currently has three silicon photonics projects in development with key partners. I thought it would ramp sometime in H2 2027, but was probably early by a few months. - Several new data center design wins, eg. 3 new SiC design wins (consistent with general 2027 ramp as 800v deployment takes off). So once those ramp in 2027-2028, (markets tend to price things ahead of time), I'd expect $XFAB to be rerated based on growth opportunities. TLDR: - Current revenue numbers not as impressive. - $XFAB confirmed direct exposure to CPO and 800V shifts (biggest win for thesis) - 800V exposure opportunities for SiC (should be 2027) - Timeline is 2028 ramp for photonics volume production Happy exposure thesis to CPO/800V was confirmed from this ER. Might be a bit of waiting for revenue ramp.

在 X 上查看原推 ↗